← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

1,400

Price

$0

Filed

Jul 15

Insider

Name

Scadden David

Title

CIK

0001707715

Roles

Director

Transaction Details

Transaction Date

2025-07-10

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,707

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | This option was granted on June 21, 2022. The shares underlying this option vest 100% one year from grant date.

Filing Info

Accession No.

0001439222-25-000084

Form Type

4

Issuer CIK

0001439222

Scadden David's History

Date Ticker Type Value
2025-11-12 AGIO M $4K
2025-11-12 AGIO $9K
2025-11-12 AGIO M $0
2025-10-08 AGIO M $4K
2025-10-08 AGIO $8K
2025-10-08 AGIO M $0
2025-09-30 AGIO M $4K
2025-09-30 AGIO $8K
2025-09-30 AGIO M $0
2025-08-27 AGIO M $4K

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$662K 2026-04-02
Jones Cecilia
Chief Financial Officer
$109K 2026-04-02
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$114K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$103K 2026-04-02